Home » Topics » Regulatory » Patents

Patents
RSS

Lilly discovers inhibitors of PSA enzymatic activity for cancer, BPH

Sep. 16, 1998

Arylsulfonamides as inhibitors of PLA2, cytokine release and neurodegeneration

Sep. 16, 1998

Anthraquinone telomerase inhibitors developed at CRC Technology

Sep. 16, 1998

Integrin antagonists discovered as part of Lilly/Cor Therapeutics collaboration

Sep. 16, 1998

Amgen describes preparation and use of KGF proteins

Sep. 15, 1998

MRI contrast agents in development at Nycomed Imaging

Sep. 15, 1998

Antigestagenic steroid esters patented by Schering AG

Sep. 15, 1998

Adrenergic agents for BPH described by Abbott in patent literature

Sep. 15, 1998

Orally active anticoagulants in early development at Gedeon Richter

Sep. 14, 1998

Inhibitors of ICE activity described by Vertex

Sep. 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...